Multiple Drug Interaction Studies On NME Peak Exposure Not Recommended
Executive Summary
FDA should not require sponsors to conduct multiple inhibitor drug interaction studies to examine maximum exposure of new molecular entities, FDA's Clinical Pharmacology Subcommittee of the Pharmaceutical Science Advisory Committee said Nov. 3